Cargando…
Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients
Nearly all patients with end-stage renal disease develop hyperphosphatemia. These patients typically require oral phosphate binders for life-long phosphorus management, in addition to dietary restrictions and maintenance dialysis. Recently, niacin, a traditional antilipemic agent, drew attention as...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206247/ https://www.ncbi.nlm.nih.gov/pubmed/25342908 http://dx.doi.org/10.2147/TCRM.S71559 |